Patrice Delafontaine

Insulin-like growth factor-1 receptor activation inhibits oxidized LDL-induced cytochrome C release and apoptosis via the phosphatidylinositol 3 kinase/Akt signaling pathway.

Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels.

Technique and imaging for transthoracic echocardiography of the laboratory pig.

Endothelial dysfunction: its role in hypertensive coronary disease.

Angiotensin II stimulates transcription of insulin-like growth factor I receptor in vascular smooth muscle cells: role of nuclear factor-kappaB.

Angiotensin II as candidate of cardiac cachexia.

Predictors of left ventricular dilatation in young adults (from the Bogalusa Heart Study).

Enhancing repair of the mammalian heart.

The ubiquitin ligase Nedd4 mediates oxidized low-density lipoprotein-induced downregulation of insulin-like growth factor-1 receptor.

IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting.

Calcific constrictive pericarditis with refractory hypokalemia in a patient with Gitelman's syndrome.

Insulin glargine reduces carotid intimal hyperplasia after balloon catheter injury in Zucker fatty rats possibly by reduction in oxidative stress.

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6.

Effect of Hurricane Katrina on the incidence of acute coronary syndrome at a primary angioplasty center in New Orleans.

Growth hormone-releasing peptide-2 suppresses vascular oxidative stress in ApoE-/- mice but does not reduce atherosclerosis.

IGF-1, oxidative stress and atheroprotection.

WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death.

Vitamin C and percutaneous coronary intervention.

IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression.

EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-kappaB andMKK7/JNK/AP-1 signaling.

Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability.

Interleukin-18 induces EMMPRIN expression in primary cardiomyocytes via JNK/Sp1 signaling and MMP-9 in part via EMMPRIN and through AP-1 and NF-kappaB activation.

Thiazolidinediones up-regulate insulin-like growth factor-1 receptor via a peroxisome proliferator-activated receptor gamma-independent pathway.

Symptoms characteristic of heart failure among CKD patients without diagnosed heart failure.

The effect of nebivolol versus metoprolol succinate extended release on asymmetric dimethylarginine in hypertension.

Interleukin-18/WNT1-inducible signaling pathway protein-1 signaling mediates human saphenous vein smooth muscle cell proliferation.

Low circulating insulin-like growth factor I increases atherosclerosis in ApoE-deficient mice.

Angiotensin-II type 1 receptor and NOX2 mediate TCF/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophy.

Angiotensin II induced catabolic effect and muscle atrophy are redox dependent.

Angiotensin II, oxidative stress and skeletal muscle wasting.

Angiotensin II upregulates protein phosphatase 2Cα and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wasting.

β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.

Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1.

Effect of Hurricane Katrina on incidence of acute myocardial infarction in New Orleans three years after the storm.

Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus.

Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy.

Aging, atherosclerosis, and IGF-1.

Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18.

Skeletal muscle molecular alterations precede whole-muscle dysfunction in NYHA Class II heart failure patients.

Insulin-like growth factor-1 regulates glutathione peroxidase expression and activity in vascular endothelial cells: Implications for atheroprotective actions of insulin-like growth factor-1.

Effect of Hurricane Katrina on chronobiology at onset of acute myocardial infarction during the subsequent three years.

Advanced oxidation protein products induce cardiomyocyte death via Nox2/Rac1/superoxide-dependent TRAF3IP2/JNK signaling.

Interleukin-18 enhances IL-18R/Nox1 binding, and mediates TRAF3IP2-dependent smooth muscle cell migration. Inhibition by simvastatin.

Persistent giant U wave inversion with anoxic brain injury.

Preoperative electrocardiogram in an 89-year-old man.

Mammographically detectable breast arterial calcification and atherosclerosis.

The therapeutic potential of IGF-I in skeletal muscle repair.

Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.

Coronary angiographic significance of hyperacute ST-T changes associated with regadenoson stress.

Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration.

Acetylsalicylic acid inhibits IL-18-induced cardiac fibroblast migration through the induction of RECK.

Docosahexaenoic acid reverses angiotensin II-induced RECK suppression and cardiac fibroblast migration.

Insulin-like growth factor-1 increases synthesis of collagen type I via induction of the mRNA-binding protein LARP6 expression and binding to the 5' stem-loop of COL1a1 and COL1a2 mRNA.

Natural disasters and myocardial infarction: the six years after Hurricane Katrina.

Interaction between insulin-like growth factor-1 and atherosclerosis and vascular aging.

Endovascular stent-graft repair of ascending aortic dissection with a commercially available thoracic endograft.

Pressure overload induces IL-18 and IL-18R expression, but markedly suppresses IL-18BP expression in a rabbit model. IL-18 potentiates TNF-α-induced cardiomyocyte death.

Angiotensin type 2 receptor signaling in satellite cells potentiates skeletal muscle regeneration.

Digital plethysmography and arginine metabolism in prehypertension: effect of nebivolol therapy.

Insulin-like growth factor I reduces lipid oxidation and foam cell formation via downregulation of 12/15-lipoxygenase.

Protein phosphatase 2C-alpha knockdown reduces angiotensin II-mediated skeletal muscle wasting via restoration of mitochondrial recycling and function.

Elevation of cardiovascular risk by non-steroidal anti-inflammatory drugs.

Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study.

The Nox1/4 Dual Inhibitor GKT137831 or Nox4 Knockdown Inhibits Angiotensin-II-Induced Adult Mouse Cardiac Fibroblast Proliferation and Migration. AT1 Physically Associates With Nox4.

TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis.

Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.

Sodium Excretion and the Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease.

TRAF3IP2 mediates atherosclerotic plaque development and vulnerability in ApoE(-/-) mice.

Rapid estrogen receptor-α signaling mediated by ERK activation regulates vascular tone in male and ovary-intact female mice.

SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis.